Nils Jakob Vest Hansen

This inventor holds 10 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Glaxosmithkline LLC, Vipergen Aps, Praecis Pharmaceuticals, Inc.. Active years: 2011-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nils Jakob Vest Hansen. Retrieved from https://idiyas.com/inventor/nils-jakob-vest-hansen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 10 (Patent Applications = 3)

% Patents Active = 90.0

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 7.9

ph-index = 4

Forward Citations = 52(Granted Patents)

Location History:

San Francisco, CA (US) (2011)
Copenhagen, DK (2011 - 2023)

Company Filing History:

Praecis Pharmaceuticals, Inc.

patents

4. 1 out of 1

Vipergen Pharmaceuticals Aps

patent

Years Active: 2011-2023

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11634835 - Method for screening of an in vitro display library within a cell (2023-04-25),

2. 10513700 - Method for making an enriched library (2019-12-24),

3. 8598089 - Methods for synthesis of encoded libraries (2013-12-03),

4. 8410028 - Methods for synthesis of encoded libraries (2013-04-02),

5. 8202823 - Structural nucleic acid guided chemical synthesis (2012-06-19),

6. 7989395 - Methods for identifying compounds of interest using encoded libraries (2011-08-02),

7. 7972994 - Methods for synthesis of encoded libraries (2011-07-05),

8. 7972992 - Methods for synthesis of encoded libraries (2011-07-05),

9. 7935658 - Methods for synthesis of encoded libraries (2011-05-03),

10. 7928211 - Method for preparing compounds by nucleic acid directed synthesis (2011-04-19),

Title: Nils Jakob Vest Hansen: Innovator in Chemical Compound Binding

Introduction

Nils Jakob Vest Hansen is a prominent inventor based in Copenhagen, Denmark, known for his significant contributions to the field of chemical biology and molecular pharmacology. With a remarkable portfolio of 10 patents, Hansen has demonstrated a consistent drive for innovation and scientific advancement.

Latest Patents

Hansen's latest patents include two notable methods that showcase his expertise in the field. The first patent is entitled "Method for screening of an in vitro display library within a cell." This method pertains to screening an in vitro display library to identify small-molecule chemical compound binding entities. The aim is to determine which entities can effectively bind to specific protein or RNA targets within a cellular environment.

The second patent, "Method for making an enriched library," involves a technique for creating an enriched library that includes specific nucleic acid sequence information. This enables the identification of binding entities that attach to specific targets, enhancing the efficiency and specificity of in vitro display libraries.

Career Highlights

Throughout his career, Nils Jakob Vest Hansen has been affiliated with several esteemed organizations. He worked at GlaxoSmithKline LLC, a leading global healthcare company known for its research and development in pharmaceuticals, vaccines, and consumer health products. He also contributed his expertise at Vipergen Aps, a company focused on drug discovery and development.

Collaborations

Hansen has collaborated with notable professionals in his field, including Barry A. Morgan and Stephen Paul Hale. These collaborations have likely been instrumental in advancing his research and expanding the boundaries of chemical compound binding technologies.

Conclusion

Nils Jakob Vest Hansen continues to be a leading figure in innovation within the scientific community. His recent patents highlight his commitment to advancing our understanding of chemical interactions in biological systems. As he develops new methodologies, his work holds the promise of significant impacts in various applications, including drug discovery and development.

Profile summary based on public USPTO records.